This action has relatively little practical consequence insofar as Vitekta and Tybost figure to see little use as standalone entities. It was a fluke that the FDA approved Stribild before approving two of its constituent drugs.
Vitekta and Tybost are already approved in the EU under the same brand names.
Market Data 
Markets 
AI
